Dr. Amita Mahajan

Major Cancer Types Treated:

• Angiosarcoma
• Basal Cell Carcinoma
• Head and Neck Cancer
• Oral Cancer
• Ovarian Cancer
• Squamous Cell Carcinoma
• Stomach Cancer
• Periampullary Cancer
• Gynaecological Cancer Treatment
• Kaposi's Sarcoma
• Laryngeal Cancer
• Non-Small Cell Lung Cancer
• Oncologic Emergencies
• Leiomyosarcoma
• Lymphoplasmacytic Lymphoma
• Malignancy
• Malignant Fibrous Histiocytoma
• Small Cell Lung Cancer
• Small Intestine Cancer
• Brain Cancer Treatment
• Breast Cancer Screening
• Genitourinary Malignancies

Sub-specialties:

• Paediatric Oncology
• Haematological Malignancy
• Solid Tumours
• Neuro-oncology
• Orthopaedic Oncology
• Bone Marrow Transplant
• Hemoglobinopathies
• Bleeding Disorders

Advanced Procedures Performed:

• Diagnosis and Treatment of Paediatric Cancers
• Management of Haematological Malignancies
• Bone Marrow Transplant procedures
• Advanced Chemotherapy Regimens
• Targeted Therapy for Paediatric Cancers
• Comprehensive Care for Hemoglobinopathies

Current & Past Hospital Affiliations:

• Current Affiliations:
• Senior Consultant, Paediatric Oncology & Haematology at Apollo Cancer Centres, Delhi
• Past Affiliations:
• Senior Consultant Paediatric Haematology & Oncology, IAH
• Consultant Paediatric Oncologist, Llandough Hospital, Cardiff, UK

Academic & Research Roles:

• Executive Member: Indian Paediatric Oncology Group
• Medical Advisor: CanKids, Leukaemia Crusaders, Thalassemics India
• Active participation in medical research and publications

Key Achievements & Contributions:

• Over three decades of dedicated service in paediatric oncology in India.
• Significant contributions to the understanding and treatment of haematological malignancies and solid tumours in children.
• Pioneering work in managing hemoglobinopathies and bleeding disorders.
• Leadership roles in national and international paediatric oncology organisations.

Dr. Amita Mahajan has received multiple awards for her significant contributions to the field of paediatric oncology. Her extensive experience and unwavering dedication have earned her recognition as a top paediatric oncologist.

Published Papers in Medical Journals:

• Thawani R, Moghe A, Idhate T, Kalra M, Mahajan A, Anderson KE. Porphyria Cutanea Tarda in a child with Acute Lymphoblastic Leukaemia. QJM (2015)
• Dhamija M, Mahajan A, Kalra M, Virmani A. Deferasirox in Indian children with thalassemia major: 3 years experience. Indian J Med Paediatr Oncol. (2013 Jan-Mar; 34(1): 16–20)
• Mittal L, Kalra M, Mahajan A. Study of Feasibility and Acceptability of Subcutaneous Implantable Ports (SIPs) in Cancer Patients. Indian J Pediatr (2012; 79(12): 1601-1604)
• Fauzdar A, Mahajan A, Jain D, Mishra M, Raina V. Amplification of RUNX1 gene in two cases of childhood B-cell precursor acute lymphoblastic leukaemia J Clin Oncol (2009; Suppl: abstr e21000)
• Fauzdar A, Jain D, Mishra M, Gupta N, Bhurani D, Mishra P, Mahajan A, Raina V. Molecular cytogenetic study in paediatric b-lineage acute lymphoblastic leukaemia: A collaborative study group from North India. J Clin Oncol (2008; Suppl: abstr e20001)
• Mahajan A, Faisal, Raina V. Acute Lymphoblastic Leukaemia: Improving outcomes in the Indian Scenario. Pediatr Blood & Cancer (2008; 48)
• Mahajan A, Sharma P. Pasha F. Feasibility of implantable ports in the Indian Scenario. Pediatr Blood & Cancer (2007; 49: PG.045)
• Mahajan A, Gupta V, Sharma P. A study of the profile of CNS tumours presenting to a new Paediatric Oncology Service in India. Pediatr Blood & Cancer (2006; 47: PJ.015)
• Steward CG, Pellier I, Mahajan A, Ashworth MT, Stuart AG, Fasth A, Lang D, Fischer A, Friedrich W, Schulz AS: Working Party on Inborn Errors of the European Blood & Marrow Transplant Group. Severe Pulmonary Hypertension: A Frequent Complication of Stem Cell Transplantation for Malignant Infantile Osteopetrosis. Br J Haematol (2004; 124(1): 63-71)
• Booms C, Mahajan A, Jenney ME. Outcome of catheter related sepsis in paediatric oncology patients. Arch Dis Child (2002; A14:G20)
• Mahajan A, Jenney ME, Doull I, Westmoreland D. RSV Bronchiolitis in immunocompromised host- the role of ribavirin? Published in the Welsh Paediatric Journal (May 2002)
• Mahajan A, Nirmal S, English MW, Jenney ME, Lazda E. Acute Tumour lysis in Hodgkin’s disease. Med Pediatr Oncol (2002; 39(1): 69-70)
• Mahajan A, Foot AB, English MW, Jenney ME. Survey of immunisation practices following completion of chemotherapeutic treatment. Arch Dis Child (2001; 84 (Suppl I): A29)
• Chowdhry VP, Lal A, Pati HP, Arya LS. Haematological responses to hydroxyurea therapy in multitransfused thalassemic children. Indian J Paediatrics (1997: 64(3): 395-8)
• Lal A, Pati HP, Arya LS, Chowdhry VP. Effect of Myleran Therapy in Multitransfused Beta-Thalassemic Children. Indian Paediatrics (1995; 32(2): 238-41)

Notable Cases Handled:
Dr. Amita Mahajan has successfully treated countless children with complex and challenging cancer diagnoses, including rare solid tumours and advanced blood disorders, providing them with renewed hope and improved quality of life. Her comprehensive approach and dedication to paediatric cancer treatment have led to numerous positive outcomes.

Patient Testimonials:

“Dr. Mahajan is an exceptionally kind and brilliant doctor. She treated my daughter for leukaemia, and her compassionate approach made a difficult time much easier for our family. We are forever grateful for her expertise and care.” – Mrs. S. Kumar

“We travelled from abroad to see Dr. Amita for our son’s brain tumour treatment. Her depth of knowledge and reassuring demeanour gave us immense confidence. The care he received was outstanding.” – Mr. T. Ahmed

“Finding a top paediatric oncologist was crucial for us. Dr. Mahajan not only provided excellent medical care for our child’s solid tumour but also ensured we understood every step of the process. Her dedication is truly inspiring.” – Ms. P. Singh

Patient-Centred Care: Dr. Amita Mahajan is dedicated to a patient-centric approach, ensuring that each paediatric cancer treatment plan is meticulously tailored to the individual needs of her young patients. She fosters a supportive and compassionate environment, involving families in every decision and empowering them through clear communication and education.

Technology & Innovation: Dr. Mahajan remains at the forefront of advancements in oncology, integrating the latest medical technology and therapeutic techniques into her practice. Her commitment to research and affiliations with leading medical institutions ensure that her patients benefit from innovative and evidence-based paediatric oncology treatments.

For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team

Language Support: The Cancer Rounds team typically offers support for international patients, including language services for seamless communication.

Visa & Travel Assistance: The Cancer Rounds team assists with visa processes, travel arrangements, airport transfers, and accommodation to ensure a smooth experience for international patients and their families.

Pre-treatment Virtual Consultations: Telemedicine capabilities are available for initial discussions, review of medical records, and second opinions, allowing international patients to consult with Dr. Amita Mahajan before travelling to India.